Targeted Treatment Plans with Adverse Event Mitigation to Improve Outcomes in Patients with BRAF-Mutated mCRC
In this module, Rona Yaeger, MD, along with Scott Kopetz, MD, PhD, course chair, will first cover strategies for modulating toxicity of targeted therapies for BRAF V600E colorectal cancer (CRC). The expert faculty will discuss best practices for improving the therapeutic index to target non-V600 BRAF mutant CRC through a discussion-based format. Recent clinical trial data, including that of the ...
View Course
View Course
An Interprofessional Team Approach to Deliver Optimal mCRC Patient Care that Addresses Disparities and Patient Education
In this module, Jamie Faber, PA-C and Tracy Trevino, BSN, RN, along with Scott Kopetz, MD, PhD, course chair, will highlight the role of the interprofessional team in administering optimal patient education and promoting compliance. Practical recommendations for addressing disparities in patient care will also be provided. Further, the expert faculty will discuss side effect management and best practices for ...
View Course
View Course
Personalized Treatment Plans for the Management of Relapsing and Progressive Multiple Sclerosis
This CE activity will highlight recent advances in the management of relapsing and progressive multiple sclerosis (MS) as presented at the Advanced Curriculum of Multiple Sclerosis 2020 annual meeting in West Palm Beach, FL. The expert faculty, Dr. Amit Bar-Or, will review the latest updates in imaging tools to improve patient diagnosis as well as discuss recent data for the ...
View Course
View Course
Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis
This CME/CE program will highlight novel BTK (Bruton’s tyrosine kinase) inhibitors and their effects on adaptive and innate immunity in multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will review BTK inhibitor science as a therapeutic target to reduce neuroinflammation and damage to the CNS in patients with MS. The faculty will analyze the safety and ...
View Course
View Course
Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events
Heart disease continues to be the leading cause of mortality in Europe. Despite advances in prevention and therapy, each year cardiovascular disease (CVD) causes over 1.8 million deaths in the European Union (EU). CVD accounts for 45% of all deaths in Europe and 37% of all deaths in the EU, is the main cause of death in men in all ...
View Course
View Course
Advanced Therapeutic Strategies and Family Planning for Women with Multiple Sclerosis
This program is derived from content presented at the Consortium of Multiple Sclerosis Centers (CMSC) 34th Annual Meeting. This CME/CE activity will highlight advanced therapeutic strategies and family planning best practices for women with multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will analyze the immunopathology, epidemiology, and immune therapeutic targets for MS. Recent clinical trial ...
View Course
View Course
A Scientific Update on Therapeutic Agents for the Reversal of Oral Anticoagulants
This CE activity will highlight recent advances in the usage of therapeutic agents for the reversal of oral anticoagulants, particularly in patients with life-threatening bleeds. The expert faculty, Dr. Charles V. Pollack Jr., will review emerging therapies for patients with uncontrolled bleeding as well as discuss the latest data on current therapeutic options for the reversal prior to urgent of ...
View Course
View Course
Novel Treatment Strategies to Improve Outcomes in Patients with Relapsing Remitting Multiple Sclerosis
This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel treatment strategies to improve outcomes in patients with relapsing remitting multiple sclerosis (RRMS). The expert faculty will review the science of relapsing remitting multiple sclerosis, including risk mitigation and the pharmacokinetics of current therapeutic options. Safety, ...
View Course
Novel S1P-Based Therapeutics to Improve Outcomes and Reduce Disability in Patients with Relapsing Multiple Sclerosis
This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel S1P-based therapeutics to improve outcomes and reduce disability in patients with relapsing multiple sclerosis. The expert faculty will review the recent science of newer S1P-based therapeutics for the treatment of patients with relapsing multiple sclerosis. Current ...
View Course
A Scientific Overview of the Pharmacological and Non-Pharmacological Treatment Strategies for Parkinson’s Disease
This continuing medical education program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), including data presented at the International Congress of Parkinson’s Disease and Movement Disorders (MDS) 2019 in Nice, France. The three expert faculty will review the pathophysiology of Parkinson’s disease, as well as best practices for early detection and diagnosis of ...
View Course
View Course
